NCT01383538 2017-08-08
FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
University of California, San Francisco
Phase 1 Completed
Clinical Trials
3 trialsNCT01255800 2014-01-31
Pilot Study of Cetuximab and the Hedgehog Inhibitor IPI-926 in Recurrent Head and Neck Cancer
University of Colorado, Denver
Phase 1 Completed
NCT00761696 2012-06-21
A Phase 1 Study of IPI-926 in Patients With Advanced and/or Metastatic Solid Tumor Malignancies
Infinity Pharmaceuticals, Inc.
Phase 1 Completed